
Research and development expenses of NeoPharm 2017-2024
In 2024, South Korean cosmetics company Neopharm spent approximately 3.4 billion South Korean won on research and development (R&D), marking an increase from the previous year. The company saw a significant rise in R&D expenses between 2017 and 2018, with spending reaching its highest level in 2024.